Dupilumab Shown to Reduce COPD Exacerbations Substantially in New Phase 3 Data
This data from the NOTUS trial is set to be submitted to the FDA alongside the phase 3 BOREAS trial data later in the year.
Georged Yancopoulos Naimish Patel Regeneron Pharmaceuticals Inc Drug Administration Regeneron Pharmaceuticals Breakthrough Therapy
Source: hcplive.com